Sensorineural Hearing Loss After Radiotherapy for Head and Neck Tumors

2008 ◽  
Vol 29 (4) ◽  
pp. 461-463 ◽  
Author(s):  
Yavuz Fuat Yilmaz ◽  
F. Ilknur Aytas ◽  
Ozgur Akdogan ◽  
Kamran Sari ◽  
Zuleyha Gorgu Savas ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Sensorineural Hearing ◽  
Head And Neck Tumors ◽  
Neck Tumors

scholarly journals Sensorineural Hearing Loss after Treatment for Head and Neck Cancer: A Review of the Literature

2014 ◽  
Vol 45 (3) ◽  
pp. 316-322 ◽  
Author(s):  
Phoebe Shorter ◽  
Fiona Harden ◽  
Rebecca Owen ◽  
Bryan Burmeister ◽  
Matthew Foote
Keyword(s):  
Hearing Loss ◽  
Head And Neck Cancer ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Neck Cancer ◽  
Sensorineural Hearing ◽  
Review Of The Literature

Risk Factors for Hearing Loss in Patients Treated With Intensity-Modulated Radiotherapy for Head-and-Neck Tumors

2009 ◽  
Vol 74 (2) ◽  
pp. 490-496 ◽  
Author(s):  
Charlotte L. Zuur ◽  
Yvonne J. Simis ◽  
Emmy A. Lamers ◽  
Augustinus A. Hart ◽  
Wouter A. Dreschler ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hearing Loss ◽  
Head And Neck ◽  
Intensity Modulated Radiotherapy ◽  
Head And Neck Tumors ◽  
Intensity Modulated ◽  
Neck Tumors

scholarly journals EP-1154: Sensorineural Hearing Loss In Patients With Head And Neck Cancer Treated With Chemo-Radiotherapy

2018 ◽  
Vol 127 ◽  
pp. S647
Author(s):  
P. D'urso ◽  
R. Cassese ◽  
B. Siniscalchi ◽  
N. Bulzonetti ◽  
D. Musio ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Head And Neck Cancer ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Neck Cancer ◽  
Sensorineural Hearing

scholarly journals Sensorineural Hearing Loss Following Irradiation to the Malignant Tumor of the Head and Neck

1989 ◽  
Vol 1989 (Supplement32) ◽  
pp. 61-66
Author(s):  
Masafumi Murakami ◽  
Hitomi Kobari ◽  
Hidetaka Kanno ◽  
Tohru Aikawa ◽  
Tomohiro Anzai ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Malignant Tumor ◽  
Sensorineural Hearing

scholarly journals Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients

2020 ◽  
Vol 16 (3) ◽  
pp. 539
Author(s):  
Susan Cheraghi ◽  
SeiedRabi Mahdavi ◽  
Abolhasan Rezaeyan ◽  
Alireza Nikoofar ◽  
Mohsen Bakhshandeh ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Head And Neck Cancer ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Sensorineural Hearing

scholarly journals Sensorineural Hearing Loss as a Sequelae of Radiotherapy and Chemotherapy in Head and Neck Cancer - An Observational Study from Maharashtra, India

2021 ◽  
Vol 10 (33) ◽  
pp. 2740-2744
Author(s):  
Sanket Chandrashekhar Prabhune ◽  
Abhay D. Havle ◽  
Swapna Ajay Shedge ◽  
Khaleel Basha Mannuru ◽  
Lakshmi Sravya Yarlagadda ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Head And Neck Cancer ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Neck Cancer ◽  
Pure Tone ◽  
Pure Tone Audiometry ◽  
Sensorineural Hearing ◽  
Group A

BACKGROUND Radiotherapy is a very well-known treatment modality for head and neck cancers besides surgery. The cochlea and its neuroepithelium are sensitive to ionizing radiation and resultant damage as it remains in the field of irradiation, the chemotherapy also has a similar effect leading to sensorineural hearing loss (SNHL). To minimize the adverse effects of hearing the advent of technology like intensitymodulated radiotherapy (IMRT) using smaller doses of radiation is now available with good control of the disease. The intended concomitant uses of chemotherapeutic agent cisplatin for increasing the sensitivity of radiation may induce ototoxicity. Both of these modalities result in a pronounced effect on highfrequency sensorineural hearing loss. We wanted to determine and compare sensorineural hearing loss amongst cases of head and neck cancer treated by radiotherapy, chemotherapy either alone or in a combination of both. METHODS All clinically diagnosed patients of head and neck cancer requiring treatment using radiotherapy or chemotherapy alone or in combination having a normal hearing on pure tone audiometry (PTA) were enrolled in the study. All enrolled cases were divided into three groups namely A, B and C based on treatment received like radiotherapy, chemotherapy and combination respectively and their effect on hearing was compared. Hearing acuity was assessed by doing PTA before and after completion of treatment and at 6 months follow up in every case. RESULTS In groups A, B and C SNHL was noted at higher frequencies of 4 kHz and 8 kHz during 1st as well as final follow up. Hearing loss was found maximum in group C receiving combination treatment compared to the other two groups receiving in isolation. Hearing loss was the least in Group - A cases that received radiotherapy using the IMRT technique. CONCLUSIONS The possibility of SNHL is increased in cases receiving a combination of radio and chemotherapy (94 %). Extra care of shielding the cochlea is essentially required during treatment with high doses (> 60Gy) using conformal radiotherapy to limit the resultant radiotherapy-induced SNHL. Radiation-induced SNHL in the IMRT technique was the least (28 %) in the group - A cases and hence should be employed in every case. Future searches for cases of head and neck malignancy the newer effective combination of chemotherapeutic drug and radiation obviating the ototoxicity needs to be continued. KEY WORDS Cisplatin, Radiotherapy, Intensity - Modulated, Audiometry, Pure - Tone, Ototoxicity, Hearing Loss, Sensorineural

scholarly journals Effects of Radiotherapy on Auditory and Vestibular Function

2014 ◽  
Vol 6 (4) ◽  
pp. 1-5
Author(s):  
Sachin Sharad Nilakhe
Keyword(s):  
Hearing Loss ◽  
Radiation Therapy ◽  
Sensorineural Hearing Loss ◽  
Head And Neck ◽  
Conductive Hearing Loss ◽  
Vestibular Dysfunction ◽  
Sensorineural Hearing ◽  
Head And Neck Malignancies ◽  
Number Of Patients ◽  
Conductive Hearing

ABSTRACT Introduction Radiotherapy either primary or adjuvant, is a commonly used modality of treatment in head and neck malignancies. The audiovestibular apparatus is often within the fields of radiation treatment, and hearing loss is a possible complication. This study was undertaken to assess the audiovestibular functions in patients undergoing radiation therapy for head and neck malignancies to determine the type and severity of hearing loss and vestibular dysfunction following radiation therapy. Materials and methods Fifty patients with head and neck malignancies reported to the malignant disease treatment center of INHS Asvini and received radiotherapy as a primary modality of treatment or in combination with surgery during the period May 2003 to Sep 2004 were included in this study. None of these patients had prior treatment by chemotherapy. Conclusion A significant number of patients who were subjected to radiation therapy for head and neck malignancies develop conductive hearing loss is predominant in the immediate postradiation period. Conductive hearing loss is reversible and improves with the conservative line of treatment. Sensorineural hearing loss more commonly affects the higher frequencies and is more common in older patients. Sensorineural hearing loss is more common when radiation doses exceed 60 Gy. There is no conclusive evidence of vestibular dysfunction in patients undergoing radiotherapy for head and neck cancers.

Sign in / Sign up

Export Citation Format

Share Document